|
New Data Showed LIVALO® (pitavastatin) Met Primary Endpoint of LDL-C Reduction ... - DigitalJournal.com (press release)
<img alt="" height="1" width="1" /> New Data Showed LIVALO® (pitavastatin) Met Primary Endpoint of LDL-C Reduction ... DigitalJournal.com (press release) [1] In addition, the effect of LIVALO and pravastatin on individual lipoprotein particles was evaluated as a pre-specified exploratory analysis using nuclear magnetic resonance (NMR) spectroscopy. LIVALO showed significantly greater reductions in total ... and more » New Data Showed LIVALO® (pitavastatin) Met Primary Endpoint of LDL-C Reduction ... - DigitalJournal.com (press release) More... |
| All times are GMT. The time now is 04:09 PM. |
Powered by vBulletin® Version 3.7.3
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
Search Engine Friendly URLs by vBSEO 3.6.0
Copyright, BioNMR.com, 2003-2013